Effect of Imatinib on histological parameters in male Swiss albino mice

A. M. Prasad, K. Ramnarayan, K. L. Bairy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cytotoxic chemotherapy for malignant disease has markedly improved the chances of long-term remission or cure in young patients who have not yet started a family. Germ cells are important targets of many chemicals. Germ cell mutagens irrespective of their chemical nature and properties, affect population of cells in the gonads, especially of testis. There is paucity of reports on planned study of imatinib on testicular function. Hence a study was planned to assess the effects of imatinib on testicular functions in male swiss albino mice. Male swiss albino mice were treated with imatinib and sacrificed at the end of 1st, 2nd, 4th, 5th, 7th and 10th week after the last exposure to imatinib. The testis were removed, weighed and processed for histological analysis. Qualitative analysis of the testis showed sloughing of the germ cells, reduction in the number of sperm cells and variation in the size and shape of the seminiferous tubules. There was not much change in the diameter of the seminiferous tubules in the treated groups except for the higher dose group. The epithelial height was reduced significantly in all treated groups. Imatinib does affect the histopathology of mice testis significantly, but this effect is reversible once the drug is withdrawn. Imatinib had demonstrated high levels of efficacy in gastrointestinal tumors and also chronic myeloid leukemia. This finding may help the clinicians to plan and address the fertility related issues in young patients of reproductive age who are being treated with imatinib for gastrointestinal tumors and chronic myeloid leukemia.

Original languageEnglish
Pages (from-to)117-122
Number of pages6
JournalInternational Journal of Pharmaceutical Sciences Review and Research
Volume4
Issue number2
Publication statusPublished - 01-09-2010

Fingerprint

Testis
Germ Cells
Seminiferous Tubules
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Sperm Count
Mutagens
Gonads
Imatinib Mesylate
Fertility
Neoplasms
Cell Count
Drug Therapy
Pharmaceutical Preparations
Population

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{5f3badef268f4c01b02c00b4f562250a,
title = "Effect of Imatinib on histological parameters in male Swiss albino mice",
abstract = "Cytotoxic chemotherapy for malignant disease has markedly improved the chances of long-term remission or cure in young patients who have not yet started a family. Germ cells are important targets of many chemicals. Germ cell mutagens irrespective of their chemical nature and properties, affect population of cells in the gonads, especially of testis. There is paucity of reports on planned study of imatinib on testicular function. Hence a study was planned to assess the effects of imatinib on testicular functions in male swiss albino mice. Male swiss albino mice were treated with imatinib and sacrificed at the end of 1st, 2nd, 4th, 5th, 7th and 10th week after the last exposure to imatinib. The testis were removed, weighed and processed for histological analysis. Qualitative analysis of the testis showed sloughing of the germ cells, reduction in the number of sperm cells and variation in the size and shape of the seminiferous tubules. There was not much change in the diameter of the seminiferous tubules in the treated groups except for the higher dose group. The epithelial height was reduced significantly in all treated groups. Imatinib does affect the histopathology of mice testis significantly, but this effect is reversible once the drug is withdrawn. Imatinib had demonstrated high levels of efficacy in gastrointestinal tumors and also chronic myeloid leukemia. This finding may help the clinicians to plan and address the fertility related issues in young patients of reproductive age who are being treated with imatinib for gastrointestinal tumors and chronic myeloid leukemia.",
author = "Prasad, {A. M.} and K. Ramnarayan and Bairy, {K. L.}",
year = "2010",
month = "9",
day = "1",
language = "English",
volume = "4",
pages = "117--122",
journal = "International Journal of Pharmaceutical Sciences Review and Research",
issn = "0976-044X",
publisher = "Global Research Online",
number = "2",

}

Effect of Imatinib on histological parameters in male Swiss albino mice. / Prasad, A. M.; Ramnarayan, K.; Bairy, K. L.

In: International Journal of Pharmaceutical Sciences Review and Research, Vol. 4, No. 2, 01.09.2010, p. 117-122.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of Imatinib on histological parameters in male Swiss albino mice

AU - Prasad, A. M.

AU - Ramnarayan, K.

AU - Bairy, K. L.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Cytotoxic chemotherapy for malignant disease has markedly improved the chances of long-term remission or cure in young patients who have not yet started a family. Germ cells are important targets of many chemicals. Germ cell mutagens irrespective of their chemical nature and properties, affect population of cells in the gonads, especially of testis. There is paucity of reports on planned study of imatinib on testicular function. Hence a study was planned to assess the effects of imatinib on testicular functions in male swiss albino mice. Male swiss albino mice were treated with imatinib and sacrificed at the end of 1st, 2nd, 4th, 5th, 7th and 10th week after the last exposure to imatinib. The testis were removed, weighed and processed for histological analysis. Qualitative analysis of the testis showed sloughing of the germ cells, reduction in the number of sperm cells and variation in the size and shape of the seminiferous tubules. There was not much change in the diameter of the seminiferous tubules in the treated groups except for the higher dose group. The epithelial height was reduced significantly in all treated groups. Imatinib does affect the histopathology of mice testis significantly, but this effect is reversible once the drug is withdrawn. Imatinib had demonstrated high levels of efficacy in gastrointestinal tumors and also chronic myeloid leukemia. This finding may help the clinicians to plan and address the fertility related issues in young patients of reproductive age who are being treated with imatinib for gastrointestinal tumors and chronic myeloid leukemia.

AB - Cytotoxic chemotherapy for malignant disease has markedly improved the chances of long-term remission or cure in young patients who have not yet started a family. Germ cells are important targets of many chemicals. Germ cell mutagens irrespective of their chemical nature and properties, affect population of cells in the gonads, especially of testis. There is paucity of reports on planned study of imatinib on testicular function. Hence a study was planned to assess the effects of imatinib on testicular functions in male swiss albino mice. Male swiss albino mice were treated with imatinib and sacrificed at the end of 1st, 2nd, 4th, 5th, 7th and 10th week after the last exposure to imatinib. The testis were removed, weighed and processed for histological analysis. Qualitative analysis of the testis showed sloughing of the germ cells, reduction in the number of sperm cells and variation in the size and shape of the seminiferous tubules. There was not much change in the diameter of the seminiferous tubules in the treated groups except for the higher dose group. The epithelial height was reduced significantly in all treated groups. Imatinib does affect the histopathology of mice testis significantly, but this effect is reversible once the drug is withdrawn. Imatinib had demonstrated high levels of efficacy in gastrointestinal tumors and also chronic myeloid leukemia. This finding may help the clinicians to plan and address the fertility related issues in young patients of reproductive age who are being treated with imatinib for gastrointestinal tumors and chronic myeloid leukemia.

UR - http://www.scopus.com/inward/record.url?scp=79952020048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952020048&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 117

EP - 122

JO - International Journal of Pharmaceutical Sciences Review and Research

JF - International Journal of Pharmaceutical Sciences Review and Research

SN - 0976-044X

IS - 2

ER -